Industry
Johnson & Johnson to buy private drug developer for $1.75 billion
Johnson & Johnson (JNJ.N) agreed to pay $1.75 billion in cash to buy privately held Alios BioPharma Inc, which is developing a drug for a common respiratory viral infection in children for which there is no approved treatment.
EBay follows Icahn's advice, plans PayPal spinoff in 2015
EBay Inc's agreement on Tuesday to spin off PayPal next year will give the unit more flexibility to strike deals in the rapidly evolving payments space as growth at the company's traditional e-commerce business slows.
UK GDP Rises Higher than Expectations in Second Quarter
UK GDP rose 0.9 percent in the second quarter, up from the expected value of 0.8 percent according to the report published by the Office for National Statistics. This increase suggests that the country is recovering faster than expected.
U.S. home prices rise less than expected in July: S&P/Case-Shiller
U.S. single-family home prices rose in July on a year-over-year basis but fell short of expectations, a closely watched survey said on Tuesday.